/

Umoja Biopharma

Develops in vivo CAR-T cell therapies to treat cancer.

BiotechnologyPharmaceuticals umoja-biopharma.com ↗

Company facts

Founded: 2019
Employees: 224
Headquarters: United States
Type: Private
Funding: Series C · $100M · 2025